Panitumumab, Gemcitabine, and Carboplatin as Treatment for Women With Metastatic Triple-Negative Breast Cancer: A Sarah Cannon Research Institute Phase II Trial - Concepedia

Concepedia

Publication | Closed Access

Panitumumab, Gemcitabine, and Carboplatin as Treatment for Women With Metastatic Triple-Negative Breast Cancer: A Sarah Cannon Research Institute Phase II Trial

44

Citations

35

References

2016

Year

Denise A. Yardley, Patrick J. Ward, Brooke Daniel, Janice F. Eakle, Ruth E. Lamar, Cassie M. Lane, John D. Hainsworth

Clinical Breast Cancer

Breast OncologyMedicineBreast CancerCancer TreatmentOncologyRadiation OncologyMolecular Oncology

References

	Year	Citations

Page 1